Basit öğe kaydını göster

Cytogenetic Studies of Chromosome Abnormalities in Thyroid Cancer Patients Before and After Iodine-131 Treatment

dc.contributor.authorDemir, Mustafa
dc.contributor.authorDeviren, Ayhan
dc.contributor.authorOden, Seda
dc.contributor.authorAtasoy, Sezen
dc.date.accessioned2021-03-05T21:03:57Z
dc.date.available2021-03-05T21:03:57Z
dc.date.issued2019
dc.identifier.citationOden S., Atasoy S., Demir M., Deviren A., "Cytogenetic Studies of Chromosome Abnormalities in Thyroid Cancer Patients Before and After Iodine-131 Treatment", BEZMIALEM SCIENCE, cilt.7, ss.118-123, 2019
dc.identifier.othervv_1032021
dc.identifier.otherav_d72c5295-2558-4927-b7db-fef2c03108ae
dc.identifier.urihttp://hdl.handle.net/20.500.12627/141976
dc.identifier.urihttps://doi.org/10.14235/bas.galenos.2018.2571
dc.description.abstractObjective: Thyroid cancer is among the most common endocrine malignancies. Initial management consists surgery and ablation. I-131,which is used to damage surgically unremoved thyroid tissue or treat metastases, is a source for ionizing radiation (IR), also generates potential mutagenic and carcinogenic effects. The purpose of research is to investigate the damage on chromosomes at the I-131 treatment of thyroid cancer patients exposed to the same dose of genotoxic agent.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleCytogenetic Studies of Chromosome Abnormalities in Thyroid Cancer Patients Before and After Iodine-131 Treatment
dc.typeMakale
dc.relation.journalBEZMIALEM SCIENCE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume7
dc.identifier.issue2
dc.identifier.startpage118
dc.identifier.endpage123
dc.contributor.firstauthorID263673


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster